P. Mauch

发表

The significance of mediastinal involvement in early stage Hodgkin's disease

P. Mauch, S. Hellman, R. Goodman, 1978, Cancer.

Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.

R. Advani, P. Bierman, L. Gordon, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Posttraumatic stress disorder (PTSD) in survivors of Hodgkin's lymphoma: prevalence of PTSD and partial PTSD compared with sibling controls

C. Recklitis, A. Ng, V. Varela, 2011, Psycho-oncology.

Murine side population cells contain cobblestone area-forming cell activity in mobilized blood.

K. Parmar, P. Mauch, Daniel Burdick, 2005, Stem cells and development.

ENGRAFTMENT FOLLOWING T‐CELL‐DEPLETED MARROW TRANSPLANTATION: I. THE ROLE OF MAJOR AND MINOR HISTOCOMPATIBILITY BARRIERS

S. Hellman, J. Lipton, J. Ferrara, 1987, Transplantation.

Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy.

J Sullivan, H. Deeg, L. Constine, 1995, International journal of radiation oncology, biology, physics.

Permanent loss in stem cell self renewal capacity following stress to the marrow.

S. Hellman, P. Mauch, M. Rosenblatt, 1988, Blood.

Functional organization of the hematopoietic stem cell compartment: implications for cancer and its therapy.

S. Hellman, P. Mauch, L. Botnick, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence of second cancers in patients treated for Hodgkin's disease.

A. Zauber, L. Bernstein, B. Zanke, 1995, Journal of the National Cancer Institute.

The importance of staging laparotomy in pediatric Hodgkin's disease.

D. Neuberg, C. Breuer, N. Tarbell, 1994, Journal of pediatric surgery.

Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor.

P. Mauch, S. Neben, P. Mauch, 1993, Blood.

Epstein-Barr Virus in Hodgkin’s Disease: Correlation of Risk Factors and Disease Characteristics with Molecular Evidence of Viral

É., G., A. Perez-Atayde, 2005 .

The involved field is back: issues in delineating the radiation field in Hodgkin's disease.

P. Mauch, J. Yahalom, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Controversies in the management of early stage Hodgkin's disease.

P. Mauch, P. Mauch, 1994, Blood.

Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.

P. Mauch, S. Hellman, S. Neben, 1993, Experimental hematology.

Granulocyte‐Colony Stimulating Factor Impedes Recovery from Damage Caused by Cytotoxic Agents through Increased Differentiation at the Expense of Self‐Renewal

P. Mauch, R. van Os, S. Robinson, 2000, Stem cells.

Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

H. Eich, A. Ng, L. Specht, 2014, International journal of radiation oncology, biology, physics.

Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.

A. Ng, L. Specht, R. Tsang, 2018, International journal of radiation oncology, biology, physics.

Lymphoid irradiation results in long‐term increases in natural killer cells in patients treated for Hodgkin's disease

R. Macklis, S. Burakoff, P. Mauch, 1992, Cancer.

Nodular lymphocyte-predominant hodgkin lymphoma.

P. Mauch, H. Tsai, 2007, Seminars in radiation oncology.

Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.

G. Pinkus, A. Perez-Atayde, I. Thior, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hodgkin's disease presenting below the diaphragm: a review.

P. Mauch, C. Portlock, J. Krikorian, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Coronary artery disease mortality in patients treated for hodgkin's disease

J. Lubin, J. Boivin, G. Hutchison, 2010, Cancer.

The role of radiotherapy for early stage Hodgkin's disease: limitations and perspectives.

J. Cosset, P. Mauch, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.

B. Silver, N. Tarbell, L. Shulman, 1997, International journal of radiation oncology, biology, physics.

The role of staging laparotomy in combined modality therapy of Hodgkin's disease: A new treatment plan based on a 6-year experience

D. Rosenthal, R. Goodman, P. Mauch, 2005, World Journal of Surgery.

Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model.

B. Yeap, P. Mauch, S. Hellman, 1989, International journal of radiation oncology, biology, physics.

An evaluation of long‐term survival and treatment complications in children with Hodgkin's disease

J. Cassady, H. Weinstein, P. Mauch, 1983, Cancer.

The influence of initial pathologic stage on the survival of patients who relapse from Hodgkin's disease.

R. Weichselbaum, D. Rosenthal, S. Hellman, 1980, Blood.

Radiation therapy in stage II ovarian carcinoma. The influence of histologic grade

C. Griffiths, R. Knapp, P. Mauch, 1980 .

An evaluation of total nodal irradiation as treatment for stage III a Hodgkin's disease

D. Rosenthal, P. Mauch, S. Hellman, 1979, Cancer.

Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment

D. Rosenthal, P. Mauch, S. Hellman, 1977, Cancer.

Cost-Effectiveness Analysis of Computerized Tomography in the Routine Follow-Up of Patients After Primary Treatment for Hodgkin's Disease

A. Ng, K. Kuntz, B. Guadagnolo, 2007 .

Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease.

A. Ng, K. Kuntz, J. Weeks, 2001, International journal of radiation oncology, biology, physics.

Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study.

D. Neuberg, J. Garber, N. Tarbell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The significance of the residual mediastinal mass in treated Hodgkin's disease.

D. Rosenthal, M. Jochelson, G. Canellos, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.

A. Ng, B. Silver, M. Stevenson, 2018, International journal of radiation oncology, biology, physics.

The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.

H. Eich, R. Advani, A. Ng, 2018, International journal of radiation oncology, biology, physics.

Hodgkin lymphoma, version 2.2015.

R. Advani, P. Bierman, L. Gordon, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study.

C. Recklitis, A. Ng, B. Silver, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

International Database on Hodgkin's Disease: a cooperative effort to determine treatment outcome.

M. Henry-Amar, P. Mauch, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Investigation : Lymphoma Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma : Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET

A. D. Van den Abbeele, A. LaCasce, P. Catalano, 2012 .

A prospective study of pulmonary function in Hodgkin's lymphoma patients.

D. Neuberg, A. Ng, B. Silver, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.

A. Ng, M. Hunink, P. Dipiro, 2014, International journal of radiation oncology, biology, physics.

Management of Lymphocyte Predominant Hodgkin Lymphoma

Ronald C. Chen, P. Mauch, 2011 .

Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.

D. Neuberg, J. Gollub, L. Shulman, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Laparotomy V ersus N o L aparotomy i n t he M anagement of E arly-Stage, F avorable-Progno sis H odgkin's D isease: A D ecision A nalysis

A. Ng, K. Kuntz, J. Weeks, 1999 .

Role of radiation therapy in localized aggressive lymphoma.

A. Ng, P. Mauch, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of early stage diffuse large B cell lymphoma, including mediastinal large cell lymphoma

P. Mauch, 1999 .

Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma.

A. Ng, B. Silver, D. Dorfman, 2002, International journal of radiation oncology, biology, physics.

Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.

G. Pinkus, B. Silver, N. Tarbell, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiac status predicts quality of life in Hodgkin's disease survivors.

A. Ng, S. Lipshultz, M. J. Adams, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.

L. Kalish, B. Silver, N. Tarbell, 1995, The cancer journal from Scientific American.

Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.

A. D. Van den Abbeele, A. LaCasce, A. Ng, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

The significance of mediastinal involvement in early stage Hodgkin's disease.

S. Hellman, R. Goodman, P. Mauch, 1977, Cancer.

What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?

G. Canellos, P. Mauch, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Shaun Parsons, E. Guinan, P. Mauch, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin ’ s lymphoma

D. Neuberg, J. Ritz, P. Mauch, 1998 .

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

D. Neuberg, J. Aster, A. Freedman, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.

K. Anderson, J. Ritz, B. Yeap, 1987, The New England journal of medicine.

Prognostic factors for positive surgical staging in patients with Hodgkin's disease.

G. Pinkus, B. Silver, D. Rosenthal, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Controversies in early-stage Hodgkin's disease.

A. Ng, P. Mauch, 2002, Oncology.

Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.

B. Silver, N. Tarbell, L. Shulman, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.

L. Kalish, D. Rosenthal, L. Shulman, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.

P. Grigsby, L. Potters, L. Gaspar, 2006, International journal of radiation oncology, biology, physics.

Mediastinal Large Cell Lymphoma: Prognostic Significance ofCT Findings at Presentation and after Treatment

L. Shulman, D. Kirn, G. Canellos, 1998, Oncology.

Sca+CD34- murine side population cells are highly enriched for primitive stem cells.

Maris Handley, K. Parmar, P. Mauch, 2003, Experimental hematology.

Workshop I: Review on prognostic factors

L. Specht, M. Henry-Amar, P. Mauch, 1992 .

Respiratory burst of neutrophils is not required for stem cell mobilization in mice

Dainius A Drukteinis, P. Mauch, R. van Os, 2000, British journal of haematology.

FDG-PET is Superior to Gallium Scintigraphy in Staging and More Sensitive in the Follow-up of Patients with de novo Hodgkin Lymphoma: A Blinded Comparison

A. D. Van den Abbeele, J. Friedberg, A. Fischman, 2004, Leukemia & lymphoma.

Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas.

D. Rosenthal, S. Hellman, S. Come, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Peri- and paracardial involvement in lymphoma: a radiographic study of 11 cases.

M. Jochelson, P. Mauch, H. Liebman, 1983, AJR. American journal of roentgenology.

A randomized phase II trial of amifostine for head and neck irradiation in lymphoma.

D. Neuberg, A. Ng, Sigui Li, 2004, Seminars in oncology.

cyclophosphamide and/or granulocyte colony-stimulating factor subpopulations from the marrow to the blood of mice following Mobilization of hematopoietic stem and progenitor cell

S. Neben, P. Mauch, K. Marcus, 2011 .

Hematopoietic stem cells in the blood after stem cell factor and interleukin-11 administration: evidence for different mechanisms of mobilization.

P. Mauch, A. Witsell, S. Goldman, 1995, Blood.

Peripheral Blood Stem Cell Transplantation: Predictions from Studies in the Mouse

S. Neben, P. Mauch, K. Chayt-Marcus, 1993 .

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Dose Intensification With Granulocyte Colony-Stimulating Factor Markedly Depletes Stem Cell Reserve for Autologous Bone Marrow Transplantation

J. Gribben, D. Neuberg, J. Ritz, 1997 .

Circulating lymphocyte populations in Hodgkin's disease after mantle and paraaortic irradiation.

E. Reinherz, S. Hellman, M. Posner, 1983, Blood.

Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.

L. Bosserman, A. Freedman, N. Tarbell, 1991, Bone marrow transplantation.

Radiotherapy in the management of localized primary cutaneous B-cell lymphoma

A. Ng, B. Silver, D. Dorfman, 2013, Leukemia & lymphoma.

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

A. Ng, L. Specht, L. Constine, 2018, International journal of radiation oncology, biology, physics.

Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.

D. Neuberg, B. Silver, Sigui Li, 2003, International journal of radiation oncology, biology, physics.

Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.

J. Loeffler, J. Cassady, H. Weinstein, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative study.

D. Rosenthal, S. Hellman, J. Ultmann, 1982, Cancer treatment reports.

Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease.

S. Hellman, P. Mauch, J. Cunningham, 1982, Cancer treatment reports.

T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications.

A. Freedman, P. Mauch, R. Soiffer, 1990, Blood.

Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.

D. Neuberg, A. Freedman, N. Spector, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.

J. Gribben, D. Neuberg, T. A. Lister, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hodgkin lymphoma.

R. Advani, P. Bierman, L. Gordon, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

The development of Graves' disease following radiation therapy in Hodgkin's disease.

J. Garber, J. Loeffler, N. Tarbell, 1988, International journal of radiation oncology, biology, physics.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

R. Advani, P. Bierman, L. Gordon, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.

P. Bierman, J. Vose, D. Neuberg, 1993, Blood.

Controversies in the use of diagnostic staging laparotomy and splenectomy in the management of Hodgkin's disease.

P. Mauch, R. Somers, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians.

D. Neuberg, A. Ng, B. Silver, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Case 43-1984: A 35-Year-Old Woman with Tracheal Stenosis after Treatment for Hodgkin's Disease

N. Harris, R. Scully, B. U. Mcneely, 1984 .

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.

A. Ng, G. Lyman, M. Hudson, 2008, International journal of radiation oncology, biology, physics.

Clinical Investigation : Lymphoma Predictive Factors for Radiation Pneumonitis in Hodgkin Lymphoma Patients Receiving Combined-Modality Therapy

A. LaCasce, A. Ng, B. Silver, 2012 .

In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients

H. Liber, K. Kelsey, J. O’Neill, 1991, Environmental and molecular mutagenesis.

Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents.

P. Mauch, J. M. Mislow, R. van Os, 1998, Blood.

Radiation therapy in Hodgkin's lymphoma.

A. Ng, P. Mauch, 1999, Seminars in hematology.

Mutagenesis after cancer therapy.

H. Liber, K. Kelsey, M. Caggana, 1993, Environmental health perspectives.

Recombinant Adeno‐Associated Virus‐Based Vectors Provide Short‐Term Rather Than Long‐Term Transduction of Primitive Hematopoietic Stem Cells

B. Du, H. Avraham, P. Mauch, 1999, Stem cells.

Clinical and Pathologic Features of Breast Cancers in Women Treated for Hodgkin's Disease: A Case‐Control Study

C. Shapiro, S. Schnitt, Jay R. Harris, 2001, The breast journal.

Four-dimensional versus 3-dimensional computed tomographic planning for gastric mucosa associated lymphoid tissue lymphoma.

A. Ng, J. Jang, P. Mauch, 2013, Practical radiation oncology.

CD 6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia in First Complete Remission

D. Fairclough, J. Ritz, A. Freedman, 1997 .

Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.

D. Neuberg, A. Freedman, L. Nadler, 2000, Experimental hematology.

Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.

R. Birdwell, D. Neuberg, A. Ng, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors.

J. Friedberg, A. Ng, B. Silver, 2002, Blood.

Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.

J. Gribben, D. Neuberg, J. Ritz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.

J. Gribben, J. Ritz, R. Soiffer, 2001, Blood.

Sexual functioning in long‐term survivors of Hodgkin's lymphoma

C. Recklitis, A. Ng, P. Mauch, 2010, Psycho-oncology.

Wide‐field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy

B. Silver, D. Rosenthal, N. Tarbell, 1993, Cancer.

Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures.

J. Greenberger, S. Hellman, P. Mauch, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Management of early stage Hodgkin's disease: the role of radiation therapy and/or chemotherapy.

P. Mauch, P. Mauch, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of early stage Hodgkin's disease: the role of radiation therapy and/or chemotherapy.

P. Mauch, P. Mauch, 1996, Bailliere's clinical haematology.

Late onset of renal dysfunction in survivors of bone marrow transplantation.

S. Sallan, E. Guinan, N. Tarbell, 1987, International journal of radiation oncology, biology, physics.

Clinical features and treatment of MALT lymphoma

P. Mauch, 1999 .

HEPATIC DYSFUNCTION FOLLOWING T‐CELL-DEPLETED ALLOGENEIC BONE MARROW TRANSPLANTATION

J. Ritz, A. Freedman, N. Tarbell, 1991, Transplantation.

Hodgkin disease/lymphoma. Clinical practice guidelines in oncology.

C. Bloomfield, R. Advani, P. Bierman, 2006, The Journal of the National Comprehensive Cancer Network.

Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphy.

P. Stomper, M. Jochelson, P. Mauch, 1988, AJR. American journal of roentgenology.

Quantitation of murine hematopoietic stem cells in vitro by limiting dilution analysis of cobblestone area formation on a clonal stromal cell line.

J. Greenberger, S. Neben, P. Mauch, 1993, Experimental hematology.

Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man.

David A. Amato, N. Tarbell, P. Mauch, 1987, International journal of radiation oncology, biology, physics.

Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.

D. Neuberg, A. Ng, B. Silver, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

1011 Comparison of MOPP versus ABVD as salvage therapy in patients who relapsed after radiation therapy alone for Hodgkin's disease

D. Neuberg, A. Ng, B. Silver, 2003 .

Transplantation with anti-B1 monoclonal antibody and complement treated autologous bone marrow for relapsed B-cell non-Hodgkin’s lymphoma

J. Ritz, L. Nadler, S. Hellman, 1985 .

Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease.

A. Ng, B. Silver, N. Tarbell, 2001, Journal of Clinical Oncology.

Results o f a P rospective T rial o f M antle I rradiation A lone for S elected P atients W ith E arly-Stage H odgkin's D isease

A. Ng, B. Silver, N. Tarbell, 2001 .

Renal insufficiency after total body irradiation for pediatric bone marrow transplantation.

E. Guinan, N. Tarbell, H. Weinstein, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Decline in bone marrow proliferative capacity as a function of age.

S. Hellman, P. Mauch, L. Botnick, 1982, Blood.

Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation.

H. Thames, N. Tarbell, P. Mauch, 1991, Blood.

Radiation therapy for orbital lymphoma.

A. Ng, B. Silver, Sigui Li, 2004, International journal of radiation oncology, biology, physics.

Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.

D. Rosenthal, S. Hellman, S. Come, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapeutic guidelines and results in advanced seminoma.

J. Richie, P. Stomper, M. Garnick, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cell types associated with fibronectin in long-term mouse bone marrow cultures.

S. Hellman, P. Hsieh, P. Mauch, 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

CULTURED CELLS IN MARROW TRANSPLANTATION 1113 recipients of cultured marrow cells with major H-2 histocompatibility differences

S. Hellman, J. Lipton, D. Nathan, 2005 .

A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation.

A. Ng, B. Silver, M. Stevenson, 2009, International journal of radiation oncology, biology, physics.

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia

K. Parmar, P. Mauch, J. Vergilio, 2007, Proceedings of the National Academy of Sciences.

Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy.

D. Rosenthal, N. Tarbell, H. Weinstein, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture.

S. Neben, J. Ferrara, D. Donaldson, 1994, Experimental hematology.

Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.

C. Coleman, B. Silver, D. Rosenthal, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.

R. Hoppe, K. Leopold, P. Mauch, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduction of treatment for early stage Hodgkin's disease.

P. Mauch, 1992, International journal of radiation oncology, biology, physics.

Anatomic substages of stage III-A Hodgkin's disease. A collaborative study.

D. Rosenthal, S. Hellman, J. Ultmann, 1980, Annals of internal medicine.

Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease.

K M Kuntz, A. Ng, K. Kuntz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis.

A. Ng, K. Kuntz, J. Weeks, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis

L. Kalish, S. Hellman, M. Kadin, 1993, Cancer.

Stage IA-IIB Hodgkin's disease: staging and treatment of patients with large mediastinal adenopathy.

D. Rosenthal, L. Shulman, H. Weinstein, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of MOPP chemotherapy in early stage Hodgkin's disease

S. Hellman, P. Mauch, 1984, Hematological oncology.

Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?

S. Hellman, P. Mauch, 1980, International journal of radiation oncology, biology, physics.

A prospective study of hprt mutant and mutation frequencies in treated cancer patients.

H. Liber, K. Kelsey, M. Caggana, 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.

B. Yeap, A. Freedman, P. Mauch, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.

J. Gribben, D. Neuberg, J. Ritz, 1996, Blood.

Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment.

P. Mauch, A. Witsell, P. Mauch, 1997, Blood.

Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.

J. Gribben, A. LaCasce, J. Friedberg, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.

J. Gribben, D. Neuberg, A. Freedman, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

with or without chemotherapy: long-term risks and risk factors Second malignancy after Hodgkin disease treated with radiation therapy

J. Friedberg, A. Ng, B. Silver, 2013 .

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

L. Kalish, B. Silver, N. Tarbell, 1996, Blood.

Radiation therapy in stage II ovarian carcinoma. The influence of histologic grade

C. Griffiths, R. Knapp, P. Mauch, 1980, Cancer.

Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.

J. Gribben, J. Friedberg, D. Neuberg, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of radiation therapy in the treatment of Hodgkin's disease.

S. Hellman, P. Mauch, 1982, Cancer treatment reports.

Late Effects of Hodgkin’s Disease and Its Treatment

A. Ng, P. Mauch, 2009, Cancer journal.

Loss of hematopoietic stem cell self-renewal after bone marrow transplantation

S. Hellman, P. Mauch, 1989 .

Stem cell self-renewal considerations in bone marrow transplantation.

S. Hellman, J. Ferrara, P. Mauch, 1989, Bone marrow transplantation.

Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy

V. Diehl, A. Ng, M. Loeffler, 2005, European journal of haematology. Supplementum.

Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome.

P Das, A. Ng, B. Silver, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

S. Lipsitz, S. Colan, S. Treves, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.

J. Friedberg, A. Ng, B. Silver, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.

J. Gribben, D. Neuberg, L. Sequist, 2005, Blood.

Autologous Bone Marrow Transplantation for Marginal Zone Non-Hodgkin's Lymphoma

J. Gribben, J. Friedberg, D. Neuberg, 2004, Leukemia & lymphoma.

Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.

J. Gribben, D. Neuberg, J. Ritz, 1999, Blood.

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.

J. Gribben, D. Neuberg, J. Aster, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma.

D. Neuberg, J. Ritz, B. Yeap, 1991, Blood.

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease

D. Fisher, R. Soiffer, E. Milford, 2004, Bone Marrow Transplantation.

Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.

J. Gribben, J. Friedberg, A. Freedman, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunogenicity of Ly5 (CD45)‐Antigens Hampers Long‐Term Engraftment Following Minimal Conditioning in a Murine Bone Marrow Transplantation Model

Dainius A Drukteinis, J. Ferrara, P. Mauch, 2001, Stem cells.

Loss of hematopoietic stem cell self-renewal after bone marrow transplantation.

S. Hellman, P. Mauch, 1989, Blood.

RECIPIENT PREPARATION FOR BONE MARROW TRANSPLANTATION I. EFFICACY OF TOTAL‐BODY IRRADIATION AND BUSLFAN

P. Mauch, J. Down, M. Warhol, 1988, Transplantation.

ENGRAFTMENT FOLLOWING T‐CELL-DEPLETED BONE MARROW TRANSPLANTATION II. STABILITY OF MIXED CHIMERISM IN SEMIALLOGENEIC RECIPIENTS AFTER TOTAL‐BODY IRRADIATION

S. Burakoff, P. Mauch, J. Ferrara, 1987, Transplantation.

Radiation sensitivity and heterogeneity of hemopoietic stem cells.

P. Mauch, J. Down, 1994, International journal of radiation oncology, biology, physics.

ENGRAFTMENT FOLLOWING T CELL‐DEPLETED BONE MARROW TRANSPLANTATION: III. DIFFERENTIAL EFFECTS OF INCREASED TOTAL‐BODY IRRADIATION ON SEMIALLOGENEIC AND ALLOGENEIC RECIPIENTS

J. Ferrara, S. Burakoff, P. Mauch, 1988, Transplantation.

CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

D. Fairclough, J. Ritz, D. Fisher, 1997, Blood.

CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.

J. Ritz, A. Freedman, P. Mauch, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

in First Complete Remission CD6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia

D. Fairclough, D. Fisher, R. Soiffer, 2013 .

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

D. Fairclough, J. Ritz, A. Freedman, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.

A. Freedman, N. Spector, P. Mauch, 1992, Journal of Clinical Oncology.

Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.

G. Pinkus, R. Mashal, L. Shulman, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lethal graft-versus-host disease: modification with allogeneic cultured donor cells.

S. Hellman, J. Lipton, D. Nathan, 1984, Blood.

Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differences

S. Hellman, J. Lipton, D. Nathan, 1985 .

Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.

A. Ng, B. Silver, M. Stevenson, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.

D. Neuberg, A. Ng, B. Silver, 2006, International journal of radiation oncology, biology, physics.

Primary Treatment Classical Hodgkin Lymphoma : Lymphocyte-predominant Hodgkin Lymphoma : NCCN Hodgkin Disease / Lymphoma Panel Members Summary of Guidelines Updates

P. Bierman, L. Gordon, D. Maloney, 2001 .

Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease.

D. Neuberg, A. Ng, B. Silver, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective.

C. Shapiro, P. Mauch, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.

G. Pinkus, M. Shipp, D. Kirn, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation.

J. Gribben, D. Neuberg, J. Ritz, 1997, Blood.

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect

J. Gribben, P. Richardson, J. Ritz, 2003, Bone Marrow Transplantation.

Late complications of therapy of Hodgkin's disease: prevention and management.

A. Ng, P. Mauch, 2004, Current hematology reports.

Three-dimensional dose distribution of total body irradiation by a dual source total body irradiator.

R. Siddon, L. Chin, N. Tarbell, 1992, International journal of radiation oncology, biology, physics.

Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long‐Term survival and relapse frequency

S. Hellman, P. Mauch, N. T. Leslie, 1985, Cancer.

Palliation for carcinoma of the esophagus.

T. Phillips, W. Wara, P. Mauch, 1976, Radiology.

Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123.

S. Berman, P. Mauch, L. B. Chen, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Primary bone lymphoma involving bilateral tibia

A. Shinagare, A. Freedman, N. Ramaiya, 2012, American journal of hematology.

Mutagenesis after therapy for Hodgkin's disease.

H. Liber, K. Kelsey, L. Shulman, 1993, Hematology/oncology clinics of North America.

Reduction of fatal complications from combined modality therapy in Hodgkin's disease.

D. Rosenthal, S. Hellman, G. Canellos, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of patients with "minimal" stage IIIA Hodgkin's disease.

W. Powlis, R. Goodman, P. Mauch, 1987, International journal of radiation oncology, biology, physics.

Concurrent management of low-risk prostate cancer and localized small lymphocytic lymphoma in a man without competing risks despite advanced age

A. D'Amico, A. Ng, J. Brock, 2014, Applied Radiation Oncology.

Prognostic factors for patients with Hodgkin disease in first relapse

P. Mauch, V. Guinee, E. A. Healey, 1993, Cancer.

Primary mediastinal large-B-cell lymphoma: radiologic findings at presentation.

L. Shulman, D. Kirn, G. Canellos, 1996, AJR. American journal of roentgenology.

Lung metastases in cervical and endometrial carcinoma.

C. D'Orsi, P. Mauch, E. Smith, 1979, AJR. American journal of roentgenology.

Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission.

N. Tarbell, L. Shulman, P. Mauch, 1998, International journal of radiation oncology, biology, physics.

Hodgkin disease/lymphoma.

C. Bloomfield, R. Advani, P. Bierman, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Thoracic irradiation in Hodgkin's disease: disease control and long-term complications.

N. Tarbell, P. Mauch, Lynn Thompson, 1990, International journal of radiation oncology, biology, physics.

Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy

A. Ng, H. Jacene, S. Kamran, 2018, Leukemia & lymphoma.

Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy.

M. Shipp, D. Rosenthal, B. Yeap, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy.

P. Catalano, A. Ng, B. Silver, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

Ronald C. Chen, D. Neuberg, G. Pinkus, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation Oncology: Technology and Biology

Jay S. Loeffler, J. Loeffler, P. Mauch, 1994 .

The Second International Symposium on Hodgkin's Disease. Workshop I: Review on prognostic factors.

L. Specht, M. Henry-Amar, P. Mauch, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)

H. Eich, R. Advani, A. Zelenetz, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose-limiting complications from upper half body irradiation in C3H mice.

N. Tarbell, P. Mauch, J. Down, 1988, International journal of radiation oncology, biology, physics.

Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.

M. Hudson, L. Constine, A. Muhs, 2008, International journal of radiation oncology, biology, physics.

Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

A. Ng, K. Kuntz, Aileen B Chen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.

C. Earle, A. Ng, K. Kuntz, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.

D. Tenen, A. Makriyannis, J. Groopman, 2011, Blood.

Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma.

A. Ng, B. Silver, A. Freedman, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Follicular non-Hodgkin's lymphoma: the role of radiation therapy

P. Mauch, 2001, Annals of Hematology.

Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.

L. Sehn, L. Shulman, A. Elias, 1998, Blood.

Hodgkin Lymphoma Version 1 . 2017 Clinical Practice Guidelines in Oncology

R. Advani, P. Bierman, L. Gordon, 2017 .

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.

A. LaCasce, A. Ng, B. Silver, 2011, Blood.

Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.

A. D. Van den Abbeele, A. Ng, B. Silver, 2005, International journal of radiation oncology, biology, physics.

Lymphoma, Hodgkin's Disease

A. Ng, P. Mauch, 2002 .

TREATMENT OF ADVANCED HODGKIN’S DISEASE

J. Armitage, L. Weiss, P. Mauch, 1977 .

Radioprotection of bone marrow stem cell subsets by interleukin-1 and kit-ligand: implications for CFU-S as the responsible target cell population.

A. Witsell, P. Mauch, C. Lamont, 1997, Experimental hematology.

Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience

A. Ng, B. Yeap, P. Mauch, 2018, Breast Cancer Research and Treatment.

Clinical course of thoracic cancers in Hodgkin's disease survivors.

A. Ng, M. Stevenson, P. Das, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

What is the role for adjuvant radiation therapy in advanced Hodgkin's disease?

P. Mauch, 1998, Journal of Clinical Oncology.

Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative.

David E Morris, Joel E Tepper, Mack Roach, 2005, International journal of radiation oncology, biology, physics.

Staging evaluation for patients with Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.

J. Glick, L. Constine, S. Leibel, 2000, Radiology.

Mantle irradiation in the upright position: a technique to reduce the volume of lung irradiated in patients with bulky mediastinal Hodgkin's disease.

G. Svensson, P. Mauch, K. Marcus, 1992, International journal of radiation oncology, biology, physics.

Fatigue in long-term survivors of Hodgkin’s disease is associated with underlying cardiac disease

D. Neuberg, C. Recklitis, A. Ng, 2004 .

Clinical Investigation : Lymphoma Low-Dose Involved-Field Radiation in the Treatment of Non-Hodgkin Lymphoma : Predictors of Response and Treatment Failure

A. Ng, B. Silver, A. Freedman, 2022 .

Implications of a proliferative limitation on hematopoietic stem cells.

S. Hellman, P. Mauch, 1984, Progress in clinical and biological research.

Bone marrow transplantation: The genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease

S. Burakoff, P. Mauch, J. Ferrara, 1985, Survey of immunologic research.

The lymphomas: current concepts in pathogenesis and management. Washington, D.C., September 21-23, 1989. Proceedings.

P. Mauch, 1990, Journal of the National Cancer Institute. Monographs.

Advances in the treatment of Hodgkin lymphoma.

P. Mauch, 2006, Clinical advances in hematology & oncology : H&O.

THE EFFECT OF DONOR T LYMPHOCYTES AND TOTAL‐BODY IRRADIATION ON HEMOPOIETIC ENGRAFTMENT AND PULMONARY TOXICITY FOLLOWING EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION

S. Neben, J. Ferrara, P. Mauch, 1992, Transplantation.

The impact of treatment on the risk of second malignancy after Hodgkin's disease.

A. Ng, P. Mauch, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-Term Competing Mortality in Early-Stage Hodgkin Lymphoma: Reduced Mortality Risk in Patients Treated in the Modern Era

A. Ng, B. Silver, P. Mauch, 2014 .

Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.

J. Glick, L. Constine, S. Leibel, 2000, Radiology.

Long-term survival and competing causes of death in Hodgkin's disease (HD)

A. Ng, B. Silver, N. Tarbell, 2000 .

Health practice in long-term survivors of Hodgkin's lymphoma.

D. Neuberg, C. Recklitis, A. Ng, 2008, International journal of radiation oncology, biology, physics.

Stem-cell biology and cancer therapy: the more things change...

S. Hellman, P. Mauch, L. Botnick, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of postoperative local or regional irradiation in the treatment of stage I ovarian cancer.

W. Powlis, R. Knapp, P. Mauch, 1982, Radiology.

Methode de depletion selective de cellules hypoxiques

P. Mauch, Kalindi Pamar, Julian D. Down, 2006 .

Prognostic factors for patients with hodgkin disease in first relapse

B. Silver, D. Rosenthal, H. Weinstein, 2022 .

Hodgkin's disease: controversies in staging and treatment

P. Mauch, 1989 .

Should lymphocyte predominance Hodgkin’s disease be treated like classical Hodgkin’s disease?

P. Mauch, 1999 .

Significance of epitrochlear lymph node involvement in Hodgkin disease

A. Ng, B. Silver, P. Mauch, 2001, Cancer.

Radiographic features of recurrent intrathoracic Hodgkin's disease following radiation therapy.

P. Costello, P. Mauch, 1979, AJR. American journal of roentgenology.

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

A. Ng, L. Specht, L. Constine, 2018, International journal of radiation oncology, biology, physics.

Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.

A. Ng, B. Silver, A. Freedman, 2012, International journal of radiation oncology, biology, physics.

Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy.

P. Catalano, A. Ng, B. Silver, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.